Chase Knickerbocker
Stock Analyst at Craig-Hallum
(4.97)
# 86
Out of 4,596 analysts
627
Total ratings
58.5%
Success rate
34.9%
Average return
Main Sectors:
Stocks Rated by Chase Knickerbocker
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PHAT Phathom Pharmaceuticals | Rated: Buy | $20 | $8.75 | +128.57% | 35 | Jul 31, 2026 | |
| BFLY Butterfly Network | Maintained: Buy | $10 | $7.11 | +40.65% | 23 | Jul 31, 2026 | |
| ETON Eton Pharmaceuticals | Maintained: Buy | $62 | $46.42 | +33.56% | 38 | Jul 28, 2026 | |
| PYPD PolyPid | Maintained: Buy | $12 | $4.29 | +179.72% | 19 | Jul 22, 2026 | |
| INDV Indivior Pharmaceuticals | Maintained: Buy | n/a | $40.01 | - | 37 | Jul 16, 2026 | |
| GUTS Fractyl Health | Reiterated: Buy | $4 | $0.685 | +483.94% | 2 | Jul 16, 2026 | |
| CELC Celcuity | Maintained: Buy | $171 → $178 | $86.38 | +106.07% | 28 | Jul 15, 2026 | |
| IRWD Ironwood Pharmaceuticals | Maintained: Buy | n/a | $4.23 | - | 33 | Jul 14, 2026 | |
| HROW Harrow | Reiterated: Buy | $59 | $38.77 | +52.18% | 45 | Jul 13, 2026 | |
| GRCE Grace Therapeutics | Maintained: Buy | n/a | $2.08 | - | 19 | Jul 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $12 | $8.08 | +48.51% | 29 | Jul 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $16 | $13.17 | +21.49% | 27 | Jul 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $4.13 | - | 44 | Jul 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $5.18 | - | 28 | Jul 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $8.12 | - | 1 | Jul 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $18.43 | - | 1 | Jun 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $6.34 | - | 24 | Jun 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $8.28 | - | 4 | Jun 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $0.4298 | - | 37 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $6.25 | - | 12 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $4.11 | - | 27 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $12.22 | - | 27 | Apr 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $9.57 | - | 33 | Apr 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $14.12 | - | 15 | Apr 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $1.1 | $1.01 | +8.91% | 16 | Mar 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $74.39 | - | 1 | Nov 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $117.82 | - | 1 | Nov 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $66.82 | - | 1 | Oct 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $38.83 | - | 1 | Oct 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $287.54 | - | 3 | Oct 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $62.83 | - | 2 | Oct 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $3.74 | n/a | 1 | Jul 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $79.98 | n/a | 1 | Jul 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $10.28 | n/a | 1 | Jul 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $12 | $8.65 | n/a | 1 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $4.81 | n/a | 1 | Feb 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $35.37 | n/a | 1 | Aug 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $38 | $18.17 | n/a | 1 | Aug 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $11.46 | n/a | 1 | Jul 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $10 | $1.98 | n/a | 1 | Mar 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $5.36 | n/a | 1 | Oct 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $1.89 | n/a | 1 | Sep 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $22.66 | n/a | 1 | Aug 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $9.14 | n/a | 1 | May 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $58 | $34.69 | n/a | 1 | May 3, 2023 |
Phathom Pharmaceuticals
Jul 31, 2026
Rated: Buy
Price Target: $20
Current: $8.75
Upside: +128.57%
Butterfly Network
Jul 31, 2026
Maintained: Buy
Price Target: $10
Current: $7.11
Upside: +40.65%
Eton Pharmaceuticals
Jul 28, 2026
Maintained: Buy
Price Target: $62
Current: $46.42
Upside: +33.56%
PolyPid
Jul 22, 2026
Maintained: Buy
Price Target: $12
Current: $4.29
Upside: +179.72%
Indivior Pharmaceuticals
Jul 16, 2026
Maintained: Buy
Price Target: n/a
Current: $40.01
Upside: -
Fractyl Health
Jul 16, 2026
Reiterated: Buy
Price Target: $4
Current: $0.685
Upside: +483.94%
Celcuity
Jul 15, 2026
Maintained: Buy
Price Target: $171 → $178
Current: $86.38
Upside: +106.07%
Ironwood Pharmaceuticals
Jul 14, 2026
Maintained: Buy
Price Target: n/a
Current: $4.23
Upside: -
Harrow
Jul 13, 2026
Reiterated: Buy
Price Target: $59
Current: $38.77
Upside: +52.18%
Grace Therapeutics
Jul 13, 2026
Maintained: Buy
Price Target: n/a
Current: $2.08
Upside: -
Jul 8, 2026
Rated: Buy
Price Target: $12
Current: $8.08
Upside: +48.51%
Jul 7, 2026
Reiterated: Buy
Price Target: $16
Current: $13.17
Upside: +21.49%
Jul 6, 2026
Maintained: Buy
Price Target: n/a
Current: $4.13
Upside: -
Jul 6, 2026
Maintained: Buy
Price Target: n/a
Current: $5.18
Upside: -
Jul 1, 2026
Maintained: Buy
Price Target: n/a
Current: $8.12
Upside: -
Jun 30, 2026
Maintained: Buy
Price Target: n/a
Current: $18.43
Upside: -
Jun 24, 2026
Maintained: Buy
Price Target: n/a
Current: $6.34
Upside: -
Jun 17, 2026
Maintained: Buy
Price Target: n/a
Current: $8.28
Upside: -
May 13, 2026
Maintained: Buy
Price Target: n/a
Current: $0.4298
Upside: -
May 11, 2026
Maintained: Buy
Price Target: n/a
Current: $6.25
Upside: -
May 5, 2026
Maintained: Buy
Price Target: n/a
Current: $4.11
Upside: -
Apr 22, 2026
Maintained: Buy
Price Target: n/a
Current: $12.22
Upside: -
Apr 22, 2026
Maintained: Buy
Price Target: n/a
Current: $9.57
Upside: -
Apr 6, 2026
Maintained: Buy
Price Target: n/a
Current: $14.12
Upside: -
Mar 10, 2026
Rated: Buy
Price Target: $1.1
Current: $1.01
Upside: +8.91%
Nov 20, 2025
Maintained: Buy
Price Target: n/a
Current: $74.39
Upside: -
Nov 19, 2025
Maintained: Buy
Price Target: n/a
Current: $117.82
Upside: -
Oct 20, 2025
Maintained: Buy
Price Target: n/a
Current: $66.82
Upside: -
Oct 17, 2025
Rated: Hold
Price Target: n/a
Current: $38.83
Upside: -
Oct 9, 2025
Maintained: Buy
Price Target: n/a
Current: $287.54
Upside: -
Oct 8, 2025
Maintained: Buy
Price Target: n/a
Current: $62.83
Upside: -
Jul 23, 2025
Rated: Hold
Price Target: n/a
Current: $3.74
Upside: n/a
Jul 22, 2025
Maintained: Buy
Price Target: n/a
Current: $79.98
Upside: n/a
Jul 14, 2025
Maintained: Buy
Price Target: n/a
Current: $10.28
Upside: n/a
Feb 26, 2025
Maintained: Buy
Price Target: $12
Current: $8.65
Upside: n/a
Feb 5, 2025
Maintained: Buy
Price Target: n/a
Current: $4.81
Upside: n/a
Aug 28, 2024
Rated: Buy
Price Target: n/a
Current: $35.37
Upside: n/a
Aug 1, 2024
Maintained: Buy
Price Target: $38
Current: $18.17
Upside: n/a
Jul 18, 2024
Initiated Coverage: Buy
Price Target: n/a
Current: $11.46
Upside: n/a
Mar 21, 2024
Maintained: Buy
Price Target: $10
Current: $1.98
Upside: n/a
Oct 16, 2023
Rated: Buy
Price Target: n/a
Current: $5.36
Upside: n/a
Sep 13, 2023
Rated: Buy
Price Target: n/a
Current: $1.89
Upside: n/a
Aug 18, 2023
Rated: Buy
Price Target: n/a
Current: $22.66
Upside: n/a
May 4, 2023
Rated: Buy
Price Target: n/a
Current: $9.14
Upside: n/a
May 3, 2023
Rated: Buy
Price Target: $58
Current: $34.69
Upside: n/a